# NRXP (NRX Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> NRX Pharmaceuticals, Inc. reported $4.31M in revenue and a net loss of $19.77M for the trailing twelve months ended September 30, 2026 (up 378.9% year over year), with a 40.0% gross margin and a -557.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/NRXP
- Markdown: https://convexityos.com/fundamentals/NRXP.md
- SEC CIK: 0001719406
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:49 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001719406&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $4.31M | +378.9% YoY |
| Operating Income | TTM | -$24.02M | -557.1% margin |
| Net Income | TTM | -$19.77M | -458.5% net margin |
| Diluted EPS | TTM | -- | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $19.82M | Total debt: $978K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.23M | $0 | $0 | -- | -- | -- | -- | -- |
| Cost of Revenue | $505K | $0 | -- | -- | -- | -- | -- | -- |
| **Gross Profit** | $720K | $0 | -- | -- | -- | -- | -- | -- |
| Research & Development | $3.78M | $6.20M | $13.37M | $17.03M | $20.26M | $10.62M | -- | -- |
| Selling, General & Admin | $13.06M | $13.50M | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | $18.50M | $27.84M | $44.34M | $115.8M | $51.39M | $713K | $1.01M |
| **Operating Income** | -$16.22M | -$18.50M | -$27.84M | -$44.34M | -$115.8M | -$51.39M | -$713K | -$1.01M |
| **EBITDA** | -$16.15M | -$18.50M | -$27.83M | -$44.33M | -$115.8M | -$51.38M | -- | -- |
| Interest Income | $12K | $44K | $494K | $249K | -- | -- | -- | -- |
| Interest Expense | $671K | $230K | $120K | -- | $18K | $56K | -- | -- |
| Income Before Tax | -- | -- | -- | -$39.75M | -$93.06M | -$51.78M | $493K | $82K |
| Income Tax Expense | $0 | $0 | $0 | -- | -- | $18K | $84K | $16K |
| **Net Income** | -$28.62M | -$25.13M | -$30.15M | -$39.75M | -$93.06M | -$51.78M | $408K | $66K |
| Basic EPS | -$1.34 | -$2.36 | -$3.98 | -$6.00 | -$19.80 | -$15.10 | -$1.10 | -$2.90 |
| **Diluted EPS** | -- | -- | -- | -$6.00 | -$19.80 | -$15.10 | -$1.10 | -$2.90 |
| Basic Shares Outstanding | 21.4M | 10.6M | 7.6M | 6.6M | 4.7M | 3.4M | 278.3K | 261.4K |
| Diluted Shares Outstanding | -- | -- | -- | 6.6M | 4.7M | 3.4M | 278.3K | 261.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.16M | $1.10M | $1.07M | $983K | $242K | $0 | $0 | -- |
| Cost of Revenue | $874K | $675K | $631K | $408K | $97K | $0 | $0 | -- |
| **Gross Profit** | $285K | $426K | $437K | $575K | $145K | $0 | $0 | -- |
| Research & Development | $1.81M | $2.12M | $1.31M | $558K | $1.43M | $987K | $804K | $1.04M |
| Selling, General & Admin | $6.56M | $4.75M | $3.81M | $4.57M | $2.81M | $2.74M | $2.94M | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- | $3.73M | -- | $2.43M |
| **Operating Income** | -$8.14M | -$6.50M | -$4.74M | -$4.62M | -$4.02M | -$3.73M | -$3.85M | -$2.43M |
| **EBITDA** | -$8.08M | -$6.43M | -$4.68M | -$4.58M | -$4.00M | -$3.73M | -$3.85M | -$3.42M |
| Interest Income | $4.0K | $6.0K | $5.0K | $4.0K | $2.0K | $2.0K | $4.0K | $4.0K |
| Interest Expense | $239K | $240K | $233K | $671K | $0 | $0 | $0 | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$2.17M | -$16.52M | -$1.43M | $360K | -$5.89M | -$17.58M | -$5.51M | -$9.08M |
| Basic EPS | -$0.05 | -$0.44 | -$0.04 | -- | -$0.27 | -$0.98 | -$0.34 | -- |
| Basic Shares Outstanding | 43.2M | 37.6M | 32.3M | -- | 22.2M | 17.9M | 16.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.80M | $1.44M | $4.59M | $20.05M | $27.61M | $1.86M | $877K | $11K | $449K |
| **Cash & Short-Term Investments** | $7.80M | $1.44M | $4.59M | $20.05M | $27.61M | $1.86M | $877K | $11K | $449K |
| Accounts Receivable, Net | $161K | $0 | -- | -- | -- | $831K | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | $26K | -- | -- | -- |
| **Total Current Assets** | $8.89M | $3.30M | $6.88M | $25.80M | $32.71M | $2.93M | $69K | $30K | $536K |
| Property, Plant & Equipment, Net | $63K | $10K | -- | -- | -- | -- | -- | -- | -- |
| Goodwill | $1.79M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Intangible Assets | $925K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $253K | $339K | $431K | $21K | $15K | $11K | -- | -- | -- |
| **Total Non-Current Assets** | $4.06M | $349K | $431K | $21K | $15K | $11K | $32.01M | $70.77M | $69.03M |
| **Total Assets** | $12.96M | $3.65M | $7.32M | $25.82M | $32.73M | $2.94M | $32.07M | $70.80M | $69.57M |
| Accounts Payable | $4.27M | $4.13M | $4.63M | $2.08M | $3.69M | $3.15M | -- | -- | -- |
| Short-Term Debt | -- | -- | $9.16M | $7.70M | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | -- | -- | -- | -- | $292K | -- | -- | -- | -- |
| **Total Current Liabilities** | $28.58M | $21.86M | $19.05M | $15.59M | $11.92M | $46.16M | $622K | $567K | $93K |
| Long-Term Debt | -- | -- | $0 | $2.82M | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $315K | $5.01M | $0 | $2.82M | $0 | $548K | $1.95M | $690K | $0 |
| **Total Liabilities** | $28.89M | $26.87M | $19.05M | $18.41M | $11.92M | $46.71M | $2.57M | $1.26M | $93K |
| **Total Debt (incl. Leases)** | $631K | -- | $9.16M | $10.53M | -- | -- | -- | -- | -- |
| Common Stock | $32K | $15K | $8.0K | $67K | $59K | $43K | $2.8K | $2.7K | $2.6K |
| Retained Earnings | -$306.9M | -$278.3M | -$253.1M | -$223.0M | -$183.2M | -$90.18M | $369K | -$39K | -$105K |
| Accumulated Other Comp. Income | -- | $0 | -$3.0K | -- | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -$15.94M | -$23.22M | -$11.73M | $7.41M | $20.81M | -$43.77M | -$4.84M | $5.00M | $5.00M |
| Total Equity | -$15.94M | -$23.22M | -$11.73M | $7.41M | $20.81M | -$43.77M | -$4.84M | $5.00M | $5.00M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $19.82M | $26.69M | $6.71M | $7.80M | $7.18M | $2.91M | $5.55M | $1.44M |
| **Cash & Short-Term Investments** | $19.82M | $26.69M | $6.71M | $7.80M | $7.18M | $2.91M | $5.55M | $1.44M |
| Accounts Receivable, Net | $218K | $206K | $181K | $161K | $239K | -- | -- | $0 |
| **Total Current Assets** | $22.21M | $29.16M | $7.36M | $8.89M | $11.95M | $4.59M | $7.26M | $3.30M |
| Property, Plant & Equipment, Net | $901K | $919K | $259K | $63K | $69K | -- | -- | $10K |
| Goodwill | $2.35M | $1.79M | $1.79M | $1.79M | $610K | -- | -- | $0 |
| Intangible Assets | $787K | $832K | $879K | $925K | $1.78M | -- | -- | $0 |
| Other Non-Current Assets | $222K | $224K | $276K | $253K | $243K | $248K | $334K | $339K |
| **Total Non-Current Assets** | $5.61M | $5.00M | $4.54M | $4.06M | $3.05M | $248K | $334K | $349K |
| **Total Assets** | $27.82M | $34.16M | $11.90M | $12.96M | $15.00M | $4.84M | $7.59M | $3.65M |
| Accounts Payable | $4.11M | $3.15M | $4.40M | $4.27M | $4.26M | $3.63M | $4.31M | $4.13M |
| **Total Current Liabilities** | $29.25M | $33.87M | $25.18M | $28.58M | $40.59M | $40.45M | $32.75M | $21.86M |
| **Total Non-Current Liabilities** | $552K | $456K | $543K | $315K | $158K | $0 | $0 | $5.01M |
| **Total Liabilities** | $29.80M | $34.33M | $25.72M | $28.89M | $40.75M | $40.45M | $32.75M | $26.87M |
| **Total Debt (incl. Leases)** | $978K | $834K | $934K | $631K | $347K | -- | -- | -- |
| Common Stock | $43K | $43K | $33K | $32K | $28K | $19K | $17K | $15K |
| Retained Earnings | -$327.0M | -$324.8M | -$308.3M | -$306.9M | -$307.3M | -$301.4M | -$283.8M | -$278.3M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Stockholders' Equity** | -$1.99M | -$170K | -$13.82M | -$15.94M | -$25.75M | -$35.62M | -$25.16M | -$23.22M |
| Total Equity | -$1.99M | -$170K | -$13.82M | -$15.94M | -$25.75M | -$35.62M | -$25.16M | -$23.22M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$28.62M | -$25.13M | -$30.15M | -$39.75M | -$93.06M | -$51.78M | $408K | $66K |
| Depreciation & Amortization | $70K | $5.0K | $5.0K | $4.0K | $2.0K | $2.0K | -- | -- |
| Stock-Based Compensation | $228K | $486K | $387K | $3.63M | $7.79M | $730K | -- | -- |
| Change in Receivables | $48K | $0 | -- | -- | $831K | -$831K | -- | -- |
| Change in Payables | $113K | -$5.22M | $2.65M | -$1.61M | -$19K | $1.18M | -- | -- |
| **Operating Cash Flow** | -$14.11M | -$10.64M | -$21.66M | -$39.76M | -$37.70M | -$2.27M | -$793K | -$473K |
| Capital Expenditure | -- | $0 | -$3.0K | -$10K | -$7.0K | -$2.0K | -- | -- |
| **Free Cash Flow** | -- | -$10.64M | -$21.66M | -$39.77M | -$37.71M | -$2.27M | -- | -- |
| Acquisitions, Net | -$2.38M | $0 | -- | -- | -- | -- | -- | -- |
| Purchases of Investments | -$432K | $0 | -- | -- | -- | -$283K | -$993K | -$690K |
| **Investing Cash Flow** | -$2.81M | $0 | -$3.0K | -$10K | -$7.0K | -$2.0K | $40.25M | -$647K |
| Common Stock Issued | $6.39M | $0 | -- | -- | -- | -$26.30M | -$40.73M | $0 |
| **Financing Cash Flow** | $23.28M | $7.49M | $6.20M | $32.21M | $63.46M | $3.25M | -$39.46M | $682K |
| **Net Change in Cash** | $6.35M | -$3.15M | -$15.46M | -$7.55M | $25.75M | $982K | -$11K | -$438K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.17M | -$16.52M | -$1.43M | $360K | -$5.89M | -$17.58M | -$5.51M | -$9.08M |
| Depreciation & Amortization | $62K | $71K | $63K | $42K | $28K | -$1.0K | $1.0K | -$990K |
| Stock-Based Compensation | $188K | $139K | $151K | $81K | $68K | $67K | $12K | $43K |
| Change in Receivables | -$24K | -$50K | -$48K | $36K | $12K | $0 | $0 | -- |
| Change in Payables | $964K | -$1.25M | $129K | $13K | $601K | -$679K | $178K | -$10.17M |
| **Operating Cash Flow** | -$6.71M | -$8.88M | -$4.29M | -$3.71M | -$2.89M | -$4.03M | -$3.48M | -$2.10M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | $0 | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -$3.48M | -$2.10M |
| Purchases of Investments | -- | -- | -$213K | -- | -- | -- | $0 | -- |
| **Investing Cash Flow** | $1.0K | -$684K | -$213K | -$249K | -$2.56M | $0 | $0 | $0 |
| Common Stock Issued | -- | -- | $3.42M | $1.64M | $3.74M | $1.01M | $0 | -- |
| **Financing Cash Flow** | -$152K | $29.53M | $3.42M | $4.58M | $9.73M | $1.39M | $7.58M | $1.90M |
| **Net Change in Cash** | -$6.86M | $19.97M | -$1.08M | $613K | $4.27M | -$2.64M | $4.11M | -$203K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 58.8% | -- | -- | -- | -- | -- | -- | -- |
| **Operating Margin** | -1324.4% | -- | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -2336.5% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -536.6% | -447.3% | -- | -- | 1.3% |
| Return on Assets (ROA) | -220.9% | -688.2% | -412.2% | -154.0% | -284.3% | -1760.5% | 1.3% | 0.1% |
| Current Ratio | 0.31x | 0.15x | 0.36x | 1.66x | 2.74x | 0.06x | 0.11x | 0.05x |
| Quick Ratio | 0.28x | 0.07x | 0.24x | 1.29x | 2.32x | 0.06x | 1.41x | 0.02x |
| Debt to Equity | -- | -- | -- | 1.42x | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -12777.2% | +517.9% | -- |
| 5Y Net Income / Share Growth | -- | -260.8% | -1674.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 40.0% | 46.6% | 50.5% | 58.8% | -- | -- | -- | -- |
| **Operating Margin** | -557.1% | -586.2% | -746.6% | -1324.5% | -- | -- | -- | -- |
| **Net Profit Margin** | -458.5% | -691.8% | -1070.3% | -2336.6% | -- | -- | -- | -- |
| Return on Assets (ROA) | -71.1% | -68.7% | -206.2% | -220.9% | -253.8% | -698.5% | -317.7% | -688.2% |
| Current Ratio | 0.76x | 0.86x | 0.29x | 0.31x | 0.29x | 0.11x | 0.22x | 0.15x |
| Quick Ratio | 0.69x | 0.79x | 0.27x | 0.28x | 0.18x | 0.07x | 0.17x | 0.07x |
| **Revenue Growth (YoY)** | +378.9% | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +96.6% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
